C-peptide/creatinine ratio in early morning urine as an indicator of residual B-cell function in insulin-dependent diabetes

Acta Paediatr Jpn. 1991 Jun;33(3):375-80. doi: 10.1111/j.1442-200x.1991.tb01569.x.

Abstract

The C-peptide/creatinine (Cr) ratio in early morning urine was evaluated to assess B-cell function. The subjects were 12 boys and 36 girls with insulin-dependent diabetes mellitus (IDDM). The controls were 130 boys and 137 girls aged 4-15 years. There was a significant inverse correlation of this ratio with the duration of insulin therapy (r = -0.5807, P less than 0.01). The daily insulin dose in U/kg was significantly different among the following groups: 1.22 +/- 0.31 U/kg in group 1 with undetectable C-peptide, 0.94 +/- 0.37 in group 2 with a decreased ratio and 0.45 +/- 0.28 in group 3 with a normal ratio. HbA1 levels were 11.3 +/- 1.6% in group 1 and 9.2 +/- 1.1% in group 3. The difference was significant. The result shows that the C-peptide/Cr ratio in early morning urine is useful for assessing B-cell function in diabetic children.

Publication types

  • Comparative Study

MeSH terms

  • Adolescent
  • Age Factors
  • C-Peptide / urine*
  • Child
  • Child, Preschool
  • Circadian Rhythm / drug effects
  • Circadian Rhythm / physiology
  • Creatinine / urine*
  • Diabetes Mellitus, Type 1 / drug therapy
  • Diabetes Mellitus, Type 1 / physiopathology*
  • Diabetes Mellitus, Type 1 / urine
  • Female
  • Glycated Hemoglobin / analysis
  • Humans
  • Insulin / administration & dosage
  • Islets of Langerhans / drug effects
  • Islets of Langerhans / physiopathology*
  • Male
  • Reference Values
  • Sex Factors
  • Time Factors

Substances

  • C-Peptide
  • Glycated Hemoglobin A
  • Insulin
  • Creatinine